| NCT ID | NCT03023046 |
| Title | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | no |
| Sponsors | University of Washington |
| Indications | |
| Therapies | |
| Age Groups: | senior adult |